Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci

Infection and Immunity

Volumn 69, Issue 8, 2001, Pages 4870-4873

  Malley, R ^a   Lipsitch, M ^a   Stack, A ^a   Saladino, R ^a   Fleisher, G ^a   Pelton, S ^a   Thompson, C ^a   Briles, D ^a   Anderson, P ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; PNEUMOCOCCUS VACCINE;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CONTROLLED STUDY; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS PNEUMONIAE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; BACTERIAL CAPSULES; CHOLERA TOXIN; DISEASE MODELS, ANIMAL; IMMUNIZATION, PASSIVE; MALE; MICE; MICE, INBRED C57BL; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0034924220     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.8.4870-4873.2001     Document Type: Article

References (28)

1. Contribution of autolysin to virulence of Streptococcus pneumoniae
2. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
3. Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults
4. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae
5. PspA, a protection-eliciting pneumococcal protein: Immunogenicity of isolated native PspA in mice
6. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA
7. Immunity to Streptococcus pneumoniae
8. The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia
9. Respiratory immunity in rabbits. VII. Resistance to intranasal infection in the absence of demonstrable antibodies
10. Epidemiology of invasive pneumococcal infections in Israel
11. Efficacy of a pneumococcal conjugate vaccine against acute otitis media
12. Intranasal vaccination against diphtheria and tetanus in human subjects
13. Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant
14. Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine
15. Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant
16. Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection
17. Bacterial vaccines and serotype replacement: Lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae
18. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae
19. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae
20. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups
21. Development of a model of low-inoculum Streptococcus pneumoniae intrapulmonary infection in infant rats
22. Destruction of low efficiency markers is a slow process occurring at a heteroduplex stage of transformation
23. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA)
24. Active and passive immunity to pneumococcus infection induced in rabbits by immunization with R pneumococci
25. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection
26. WHO meeting on maternal and neonatal pneumococcal immunization
27. Establishment of a Streptococcus pneumoniae nasopharyngeal model in adult mice
28. Epidemiology of invasive pneumococcal disease in southern California: Implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial